D
David Spiegel
Researcher at Stanford University
Publications - 838
Citations - 50967
David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.
Papers
More filters
Journal ArticleDOI
IFP News Section
Nicoletta Sonino,Giovanni A. Fava,Chantal Henry,Katia M'Bailara,Rollon Poinsot,Anne-Aurelie Casteret,Frédéric Sorbara,Marion Leboyer,Eduard Vieta,Ludwig Grepmair,Ferdinand Mitterlehner,Thomas H. Loew,Egon Bachler,Wolfhardt K. Rother,Marius Nickel,Axel Schweickhardt,Astrid Larisch,Michael Wirsching,Kurt Fritzsche,Carlo Faravelli,Mario Catena,Alessandra Scarpato,Valdo Ricca,Michael Martini Jørgensen,Martin Härter,Harald Baumeister,Katrin Reuter,Frank Jacobi,Michael Höfler,Jürgen Bengel,Hans-Ulrich Wittchen,Robert Zachariae,Axel Skytthe,Kirsten Ohm Kyvik,R. Zachariae,K. Paulsen,M. Mehlsen,A.B. Jensen,A. Johansson,H. von der Maase,Fabio Facchinetti,Fedra Ottolini,Marta Fazzio,Marco Rigatelli,Annibale Volpe,Naheed K. Hossain,Jane Irvine,Paul Ritvo,Helen S. Driver,Colin M. Shapiro,Constance J. Dalenberg,Richard J. Loewenstein,David Spiegel,Chris R. Brewin,Ruth A. Lanius,Steven Frankel,Steven N. Gold,Bessel A. van der Kolk,Daphne Simeon,Eric Vermetten,Lisa D. Butler,Cheryl Koopman,Christine A. Courtois,Paul F. Dell,Ellert R. S. Nijenhuis,James A. Chu,Vedat Sar,Oxana Palesh,Carlos De las Cuevas,Kelsey Paulson,Harrison G. Pope,Steven Barry,J. Alexander Bodkin,James I. Hudson,Carlo Lai,Silvia Daini,Maria Lucia Calcagni,Isabella Bruno,Sergio De Risio,Marco Chiesa,Peter Fonagy,Sabine Loeber,Bernhard Croissant,Helmut Nakovics,A Zimmer,Alexander Georgi,Sabine Klein,Carsten Diener,Andreas Heinz,Karl Mann,Herta Flor +90 more
TL;DR: The hosts of the congress hosted the GermanChinese Academy for Psychotherapy in cooperation with the China Association for Mental Health, Division of Psychotherapy and Counseling, the Chinese Psychological Society, Division for University Students Psychological Counseling and the Shanghai East Hospital.
Journal ArticleDOI
Abstract CT244: A phase 1a/1b study of STK-012, an α/β IL-2 receptor selective partial agonist as monotherapy and in combination with pembrolizumab in advanced solid tumors (NCT05098132)
David Spiegel,Alexander I. Spira,Dmitriy Zamarin,David F. McDermott,Jason J. Luke,John V. Heymach,Rebecca A. Previs,Ryan J. Sullivan,Leena Gandhi,Alex Azrilevich,Naiyer A. Rizvi,Martin Oft,Natalie Busby,Benjamin Izar +13 more
TL;DR: This is a first-in-human, open-label, dose escalation and expansion study in adults with advanced solid tumors to evaluate the safety, pharmacokinetics, immunogenicity, preliminary efficacy, and pharmacodynamics of STK-012 as monotherapy and in combination with pembrolizumab.
Journal ArticleDOI